ロード中...
Controversies in clinical cancer dormancy
Clinical cancer dormancy is defined as an unusually long time between removal of the primary tumor and subsequent relapse in a patient who has been clinically disease-free. The condition is frequently observed in certain carcinomas (e.g., breast cancer), B-cell lymphoma, and melanoma, with relapse o...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
National Academy of Sciences
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3145712/ https://ncbi.nlm.nih.gov/pubmed/21746894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1106613108 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|